Acrivon Therapeutics

2 open jobs

Acrivon is a clinical stage biopharmaceutical company discovering and developing precision medicines using its proprietary Generative Phosphoproteomics AP3 platform to interpret drug-regulated pathway activity and design differentiated compounds. The company is advancing its lead program ACR-368 (prexasertib), a selective small molecule inhibitor for endometrial cancer, and has additional oncology development candidates in its pipeline.